Journal of Medicinal Chemistry p. 1556 - 1564 (2016)
Update date:2022-08-03
Topics:
Kuntz, Kevin W.
Campbell, John E.
Keilhack, Heike
Pollock, Roy M.
Knutson, Sarah K.
Porter-Scott, Margaret
Richon, Victoria M.
Sneeringer, Chris J.
Wigle, Tim J.
Allain, Christina J.
Majer, Christina R.
Moyer, Mikel P.
Copeland, Robert A.
Chesworth, Richard
Posttranslational methylation of histones plays a critical role in gene regulation. Misregulation of histone methylation can lead to oncogenic transformation. Enhancer of Zeste homologue 2 (EZH2) methylates histone 3 at lysine 27 (H3K27) and abnormal methylation of this site is found in many cancers. Tazemetostat, an EHZ2 inhibitor in clinical development, has shown activity in both preclinical models of cancer as well as in patients with lymphoma or INI1-deficient solid tumors. Herein we report the structure-activity relationships from identification of an initial hit in a high-throughput screen through selection of tazemetostat for clinical development. The importance of several methyl groups to the potency of the inhibitors is highlighted as well as the importance of balancing pharmacokinetic properties with potency.
View MoreChangzhou Kingyo Chemical Corporation Ltd.
website:http://www.kingyochem.com
Contact:+86-519-85105717
Address:19# Wuqing North Road, Changzhou , Jiangsu, China
SHANGHAI RORY FINE CHEMICALS CO.,LTD
Contact:0086-21-50702305/50343389
Address:Pudong Avenue 3040 building 2 room 103/50343389
Contact:+86-512-69561895
Address:No.111, Building A4, 218 Xinghu Street, Suzhou Industrial Park, P. R. China
Jinan YouCheng Pharmatech Co.,Ltd
Contact:+86-18653163205
Address:No.750, Shunhua Road, University Science Park, High-tech Zone, Jinan City
Feiyang Biotechnology Co., Ltd.
Contact:+86-533-7866339
Address:Qilu Chemistry Park, 200m north of Management Community Building of Park
Doi:10.1055/s-1993-25809
(1993)Doi:10.1016/j.ssc.2005.08.021
(2005)Doi:10.14233/ajchem.2015.17144
(2015)Doi:10.1016/S0957-4166(00)80191-3
(1992)Doi:10.1002/anie.202010682
(2020)Doi:10.1080/10610278.2012.720021
(2012)